Overview

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.
Phase:
Phase 3
Details
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Treatments:
Miglitol